Higher standards needed for human clinical drug trials


A recent commentary written by McGill’s Dr. Jonathan Kimmelman and colleagues, argues that some painful procedures used in clinical trials, such as serial biopsies of patients with advanced cancer seeking treatment are not well thought out, leading to unnecessary burden for patients in trials.